Background: Cyclin-dependent kinases (CDKs) are thought to initiate and coordinate cell division processes by sequentially phosphorylating key targets; in most cases these substrates remain unidentified.
Background
Protein phosphorylation is an important regulator of the cell-cycle transition from interphase to mitosis; several protein kinases are required [1] [2] [3] [4] [5] [6] , and there is a dramatic increase in phosphate turnover during mitosis, accomplished by activating both protein kinases and protein phosphatases [7, 8] . Over 50 proteins become specifically phosphorylated in mitosis and react with the anti-phosphoepitope monoclonal antibody MPM-2 [9] . This antibody stains kinetochores, centrosomes, polar microtubules, and the central axis of chromosomes, suggesting that the mitotic reorganization of most of the structural components of the cell may be under phosphorylation control [10, 11] .
The cell cycle is controlled by a family of cyclin-dependent kinases (CDKs), which are sequentially activated by the synthesis and destruction of their cyclin regulatory subunits (reviewed in [12] ). In metazoans, there appears to be temporal regulation of two families of mitotic cyclins, namely A-type and B-type cyclins. It is believed that the complex of Cdc2 (also known as p34 cdc2 ) and cyclin A is activated in G2 and early prophase, whereas complexes of both A-type and B-type cyclins with Cdc2 are activated during prophase and metaphase, and only B-type cyclins are present during late metaphase, after the A-type cyclins have been degraded [4, 13, 14] .
To understand how an enzyme regulates a biological process, it is first necessary to identify its substrates. We know that activation of Cdc2 is necessary to trigger mitosis, but only through the identification of a few key substrates have we gained an insight into how this is accomplished. For example, mutagenesis of the Cdc2 phosphorylation sites on lamin A inhibits nuclear envelope breakdown, demonstrating that Cdc2 can directly control a structural component of the cell that is remodeled during mitosis [15, 16] . Yet most of Cdc2's key targets involved in other mitotic events have not been identified. Cell-cycle regulation is further complicated by the fact that many substrates are regulated by multiple kinases. For example, there are additional mitotically phosphorylated sites on lamins [17] that are targets of the ␤ isoform of protein kinase C (PKC), and still other sites for which the kinase is not known [18] . Genetic and biochemical studies have identified several protein kinases essential for mitosis [6, 19] : although the best characterized are the CDKs [1, [4] [5] [6] , additional kinases such as NimA, isoforms of PKC, and Polo/Cdc5 are thought to be essential for mitotic progression [2, 3, 18, 19] . It remains unclear whether these identified protein kinases are responsible for the bulk of mitotic phosphorylation, or whether they serve limited roles in mitosis -additional uncharacterized kinases may also participate in mitotic events.
Identifying either a complete or arbitrarily chosen set of cell-cycle specific phosphoproteins could be useful in examining cell-cycle regulation. By determining the percentage of proteins that are recognized by CDKs, one could assess the relative contributions of CDKs and other kinases to cell-cycle specific phosphorylation. Moreover, the characterization of these phosphoproteins should identify the kinase substrates that are regulating cell-cycle events, and the proteins could be used to detect previously unidentified cell-cycle specific kinase activities. Unfortunately, such unbiased sets of cell-cycle specific phosphoproteins cannot be generated with existing techniques, with which kinase substrates are detected by testing known proteins with known kinases.
In this study, we present a systematic and broadly applicable screen for kinase substrates. We have translated in vitro cDNA pools consisting of only 100 clones from a Xenopus laevis gastrula-stage library [20, 21] to directly prepare pools of 35 S-labeled proteins. The phosphorylation of these library proteins by kinases in mitotic and interphase cell extracts was detected either by scoring for phosphatase-sensitive alterations in mobility when analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) or by immunoprecipitation with phosphoepitope-recognizing antibodies. Using this approach, we have isolated cDNAs encoding 20 proteins that are phosphorylated in a mitosis-specific manner. The genes we isolated using these cDNAs encode previously identified regulators of mitosis as well as novel proteins. Not all of these putative mitotic phosphoproteins can be directly phosphorylated by Cdc2, suggesting that they must be substrates of other mitotic kinases.
Results

Development of a screen for mitotic phosphoproteins
Whether a protein is phosphorylated in vivo is determined by factors that may change dramatically during the cell cycle, including the affinity of the kinase for the substrate, the localization of kinases and substrates, the activity of phosphatases, and the activity of kinase docking and accessory factors [22] . As these dynamics are often lost upon enzyme purification, we have instead used cell-cycle staged Xenopus egg extracts to study mitotic phosphorylation. Interphase extracts form nuclei around DNA and replicate the chromosomes once and only once, and mitotic extracts are able to disassemble nuclear envelopes, condense chromosomes, and form metaphase spindles [23, 24] , recapitulating the events of the cell cycle in vitro. The extracts would therefore be expected to reproduce physiological phosphorylation and dephosphorylation. Thus, using these extracts, we hoped to test not only the capacity of a site for phosphorylation but the stoichiometry of that event in a physiologically relevant cellular milieu.
We have developed two complementary approaches to identifying mitotic phosphoproteins (Fig. 1a) . In both approaches, pools of clones from a Xenopus gastrula-stage cDNA library (containing approximately 100 clones per pool) were first transcribed and translated in vitro to generate pools of radiolabeled proteins. These protein pools were then incubated in mitotic or interphase Xenopus egg extracts. Proteins that become phosphorylated after incubation in the mitotic, but not the interphase, extract were identified by looking for alterations in their mobility upon gel electrophoresis. Alternatively, mitosis-specific phosphorylation of the radiolabeled library proteins was detected by immunoprecipitation with the anti-phosphoepitope antibody MPM-2.
We used the mitotic phosphatase, Cdc25 (from Xenopus), as a positive control in both assays; the mitotic form of Cdc25 is recognized by the MPM-2 antibody and migrates more slowly than its interphase form upon gel electrophoresis [25, 26] . The protein kinase Cdc2 (from Xenopus) was used as a negative control, as its gel mobility does not change nor does it become reactive to the MPM-2 antibody. After incubation in a Xenopus mitotic extract, in vitro translated Cdc25, but not Cdc2, migrated with a reduced mobility and was immunoprecipitated by the MPM-2 antibody (Fig. 1b) . When either protein was incubated in an interphase extract, its mobility was not affected and it was not appreciably immunoprecipitated by the MPM-2 antibody.
Identification of mitotic phosphoproteins
In the screen for gel-mobility shifts, 69 library pools out of 232 tested contained at least one protein whose mitotic form migrated more slowly than its interphase form. Two examples of positive pools are shown in Figure 1c . Almost all of the proteins in each pool had a similar mobility after incubation in interphase or mitotic extracts -the arrows point to the single protein in each pool with a reduced mobility after incubation in mitotic extracts. This reduced mobility was phosphatase sensitive (data not shown), suggesting that it was indeed a consequence of mitotic kinase activity. The extent of the mobility shift varied considerably between different clones, with the apparent molecular mass changes ranging from 1 to 30 kD. The mobility change of a single protein within a pool was very reproducible from experiment to experiment.
Some of the positive pools (14/69) were selected for subdivision because they contained proteins that showed a large shift in mitotic extracts and were of different apparent molecular masses. These pools were progressively subdivided and retested until single active clones were identified ( Table 1 ). The cloned cDNAs encoded nine different proteins, which we hereafter refer to as mitotic phosphoproteins (MPs); newly identified MPs were named by appending the apparent molecular mass of the gene product. One MP, Sox3, was identified three times, MP105 was identified twice, and the other seven MPs were each identified once. When tested individually, all nine MPs reproducibly exhibited phosphatase-sensitive reductions in gel mobility when incubated in mitotic extracts (Fig. 2a) . For example, MP68 stoichiometrically shifted from a single band of an apparent molecular weight of 68 kD in an interphase extract to a doublet of 75 and 77 kD in a mitotic extract; this reduction in mobility was sensitive to phosphatase treatment ( Fig. 2a ; compare the mobility of MP68 in lanes 1, 2 and 3). MP110, by contrast, was not stoichiometrically shifted in mitotic extracts, but instead ran on SDS gels as a smear of slower migrating species. Many MPs displayed multiple phosphorylated forms which appeared as smears on SDS gels following incubation in mitotic extracts (Fig. 2a) ; these smears suggest that the proteins are heterogeneously phosphorylated.
A complementary screen was performed using MPM-2 antibody recognition as an assay of mitotic phosphorylation. The pools contained between 20 and 30 labeled proteins (Fig. 1d, lanes 1,4,7) , most of which were not recognized by the MPM-2 antibody after incubation in either interphase or mitotic extracts (Fig. 1d) . A few proteins were immunoprecipitated after incubation in either extract; the arrows in Figure 1d point to proteins that were only immunoreactive after incubation in a mitotic extract. Several pools tested (36/265) contained a protein that could be immunoprecipitated with the MPM-2 antibody in a mitosis-specific manner. Of the 36 positive pools, the first 12 that contained bands which were clearly immunoprecipitable by the MPM-2 antibody were subdivided and retested to yield 11 unique cDNA clones ( Table 1) . One of these, encoding MP25, was isolated twice, and the other 10 clones were isolated once each.
Characterization of the mitotic phosphorylation patterns of the individual MPs isolated by MPM-2 recognition is shown in Figure 2b . For example, the clone MP44 was stoichiometrically shifted from a 44 kD species in interphase extracts to a smear of forms that ranged in apparent molecular weight from 50 to 55 kD in mitotic extracts ( Table 1 ), and as single clones, nine of eleven MPs were recognized by MPM-2 after incubation in mitotic extract (Fig. 2b , lanes 4,5; Table 1 ). Two proteins (Vent2 and MP70) were recognized by MPM-2 only if the phosphatase inhibitor okadaic acid was included in the mitotic extract (data not shown); both these proteins exhibited gel-mobility shifts in mitotic extracts. Three MPs showed no obvious gel shifts but were still identified by the MPM-2 antibody in the mitotic state, demonstrating that the two screening approaches were complementary.
In the described MPM-2 recognition screen, MPM-2 immunoprecipitations were performed under native conditions, and it was therefore possible that we had detected proteins that bound to other proteins that themselves had MPM-2 immunoreactivity. In order to address this possibility, the individual clones were denatured after incubation in extracts, and then immunoprecipitated. Under denaturing conditions, five of the nine proteins (MP90, MP43, MP44, HoxD1 and MP42) could be precipitated by MPM-2 and therefore can be called 'true' MPM-2 antigens (Fig. 2b , first five clones). The other proteins could be precipitated by MPM-2 only under native conditions, and therefore they might associate with other MPM-2 antigens, or they may only be recognized by MPM-2 under native conditions. The human homolog of one of these proteins, MP20, was previously identified as a true MPM-2 antigen [27] . Ribosomal elongation factor 1␥ (EF1␥) was previously shown to be a mitotic phosphoprotein [28] , and MP130 had a retarded migration on SDS gels after incubation in a mitotic extract; hence, even the MPM-2 antigens that could be immunoprecipitated only under native conditions are probably phosphorylated mitotically in vivo.
In summary, using both of our screening approaches, we have screened a total of about 500 pools of cDNAs (encoding approximately 12 000 proteins), and have identified 105 pools that contain potential mitotic phosphoproteins. Of these positive pools, 26 have thus far been progressively subdivided to yield 17 cDNAs that code for proteins that displayed reduced mobility after incubation in mitotic extracts, and 3 additional clones that code for proteins that either are themselves mitotic phosphoproteins or were detected in complexes with proteins containing MPM-2 antigens ( Table 1 ). The screen is clearly not yet saturated: there are many more positive pools to be subdivided, and only three clones (MP105, Sox3 and MP25) were identified more than once each.
Sequence analysis of cloned mitotic phosphoproteins
The cDNA insert from each of the 20 plasmid clones isolated was partially sequenced and compared to sequences in the GenBank nonredundant database [29] . Fifteen of the clones are related to previously identified proteins ( Table  2) . Seven of the clones have been previously cloned in Xenopus -those encoding Oct91, HoxD1, Vent2, EF1␥, Sox3 and two isoforms of Xbr1 -and seven others exhibit strong sequence similarity to genes previously cloned from other species -those encoding MP130 (inner-centrosome protein; INCENP), MP110 (Schizosaccharomyces pombe Cdc5), MP30 (negative co-factor 2␣; NC-2␣), MP70 (BRG1/Swi2), MP25 (RNA helicase WM6), MP20 (ribosomal protein L18A) and MP105 (a glycophosphatidylinositol The sequenced regions of the other five putative substrates identified do not bear significant similarity to known proteins. MP90 and MP44, however, are homologous to open reading frames identified in the budding yeast and Caenorhabditis elegans genome sequencing projects (Table 2) . A search for a conserved domain or motif among all the clones was unproductive, although most of the MPs contain a region that has multiple serine-proline or threonine-proline pairs (data not shown), including consensus phosphorylation sites for Cdc2 and mitogenactivated protein (MAP) kinase (Table 2) . A similar motif is mitotically phosphorylated in Cdc25 [30] , and is found in many mitotic regulators including Wee1 and Cdc27 [31] . There are 35 consensus Cdc2 or MAP kinase phosphorylation sites in the 18 substrates we have identified that have been fully sequenced; only 8 such sites would be predicted to occur in a similar amount of random sequence, and when we searched 20 protein sequences picked at random, the sites were detected 12 times (P.T.S. and M.W.K., unpublished observations).
X-INCENP is a physiologic substrate of mitotic kinases
In order to establish that the INCENP-related protein, MP130 (hereafter referred to as Xenopus INCENP; X-INCENP), is a mitotic phosphoprotein in vivo, we used a cross-reacting antibody raised against chicken INCENP to examine the phosphorylation of endogenous X-INCENP during early embryonic cell cycles. Xenopus eggs were fertilized and, at intervals thereafter, embryos were lysed in buffer containing both kinase and phosphatase inhibitors (Fig. 3) ; a portion was removed to assay kinase activity against histone H1, and the rest was diluted into SDS-containing sample buffer for immunoblot analysis. Figure 3a shows that the change in relative mobility of X-INCENP incubated in Xenopus extracts in vitro was similar to the change in mobility observed in vivo. Two mobility forms of the protein were observed following incubation in interphase extracts of in vitro translated X-INCENP; endogenous X-INCENP showed a similar mobility pattern when isolated from interphase embryos. The slower migrating form may be unphosphorylated, as it comigrated with the phosphatase-treated protein ( Fig. 3a;  compare lanes 1 and 3) . The X-INCENP protein exhibited reduced mobility in mitotic extracts and in embryos that were in the mitotic phase of the cell cycle ( Fig. 3a; compare lanes 2 and 5). As Xenopus embryos traversed the early cell cycles, the appearance of the slowest migrating form of X-INCENP correlated with increased kinase activity, assessed using histone H1 as a substrate (Fig. 3b) -a measure of Cdc2 activity. This data suggests that our screen is capable of identifying physiological protein kinase substrates.
Phosphorylation of mitotic phosphoproteins by Cdc2 and by distinct mitotically activated kinases
Although CDKs have been demonstrated to phosphorylate certain substrates directly during mitosis, CDKs could also act indirectly to modify the phosphorylation state of a protein. For example, CDKs could either activate a downstream mitotic kinase, inhibit a phosphatase to reveal a constitutive kinase activity, modify a substrate so that it can be phosphorylated by another kinase, or regulate proteins that render substrates sensitive to other kinases. To determine whether Cdc2 can directly phosphorylate the identified MPs, the individual in vitro translated proteins were incubated with affinity-purified cyclin B-Cdc2 (Fig. 2a, lane 4) , and the mobility of the protein on SDS gels was compared with the mobility of the proteins observed following incubation in either mitotic extracts (Fig. 2a, lane 2) or mockpurified kinase solutions (Fig. 2a, lane 5) . The level of histone H1 kinase activity was titrated to about the same level as that found in a mitotic extract; in the absence of phosphatases, this presumably represents a large excess of kinase activity. Of the 16 proteins assayed, 14 exhibited reduced mobility after incubation with cyclin B-Cdc2 ( Fig.  2a ; Table 2 ). The full mobility shift of MP68, MP48, MP110, Xbr1b, Oct91 and MP30 could be reconstituted by incubation with cyclin B-Cdc2, but treatment with cyclin B-Cdc2 did not result in the same reduction in mobility of MP75 and Sox3 as was observed following incubation in mitotic extract. The mobility of two proteins, MP105 and MP70, was not altered at all by incubation with and MP43, the clones were only partially sequenced on one strand. Therefore, the degree of homology is presented as the number of identical amino acids relative to the number of amino acids coded within the sequenced region. ‡ Consensus phosphorylation sites for Cdc2 and mitogen-activated protein (MAP) kinase were taken as Ser/Thr-Pro-X-Arg/Lys and Pro-X-Ser/Thr-Pro, respectively. Unless the identified clone was fully sequenced, the kinase consensus site information was generated from the homologous clone. § The ability of purified cyclin B1-Cdc2 to alter the gel mobility of the MPs in vitro was compared to the mobility shifts produced in a mitotic extract in an experiment similar to that shown in Figure 2a , and scored as either no shift by Cdc2 (-), partial shift when compared to mitotic extract (+), or the same shift as the mitotic extract (++); some proteins were not scored (ND) because phosphorylation of the clone did not cause a significant gel-mobility change.
purified cyclin B-Cdc2. The results of similar assays performed with the MPs that were identified by MPM-2 recognition and that change mobility in extracts are summarized in Table 2 .
Discussion
In a nonsaturated, systematic screen for gene products that are phosphorylated by cell-cycle-regulated protein kinases, we have identified 20 different proteins that are phosphorylated in a mitosis-specific manner. At least 6 of these MPs are MPM-2 antigens; 15 share sequence similarity with previously characterized proteins, and the other 5 appear not to have been identified previously. Of the 16 proteins tested, 14 were substrates of cyclin B-Cdc2 in vitro.
Possible roles of mitotic phosphoproteins in mitosis
Microtubules are reorganized during mitosis to generate a spindle. E-MAP-115, a homolog of MP75, appears to stabilize microtubules in interphase [32] . E-MAP-115 is bound to microtubules during interphase, dissociates from microtubules during early prophase, and slowly reassociates with the spindle after late prophase [33] . Moreover, E-MAP-115 is hyperphosphorylated in mitosis in vivo, and hyperphosphorylated E-MAP-115 does not bind microtubules in vitro [33] . Therefore, the screening method has identified a protein that appears to be regulated by mitosis-specific phosphorylation.
INCENP (MP130) also appears to have a mitotic role. In somatic cells, INCENP is bound to chromosomes in prophase, moves to the centromeres at metaphase, migrates to the polar microtubules in anaphase, and finally resides in the midbody [34] . The multiple mitotic phosphoforms of INCENP in vivo provide a potential mechanism for regulating INCENP localization; we are currently determining whether nonphosphorylatable mutants of the INCENP protein still exhibit dynamic localization patterns during the cell cycle.
MP110 is similar to Cdc5 of S. pombe and to a presumptive human homolog [35, 36] . In S. pombe, the cdc5 + gene is essential; cdc5 -cells replicate their DNA but are unable to undergo mitosis [35] . Cdc5 is related to the Myb transcriptional activator, binds DNA cellulose, and may be a transcription factor active only during the G2 phase of the cell cycle [35] .
In fact, mitotic phosphorylation may be a general mechanism to remove regulatory proteins from chromatin. There is a decrease in transcription during mitosis [37, 38] , and a number of transcription factors are phosphorylated during mitosis, including the homeobox gene GHF-1, Myc, Myb, BRG1, Oct1, Swi5 and TFIID [39] [40] [41] [42] [43] . We have added eight new members to this list, suggesting that transcription factors may be generally phosphorylated in mitosis. Moreover, mitotic phosphorylation dissociates a number of transcription factors from chromatin, including Myb, BRG1 and GHF-1 which are homologous to MP110, MP70 and the Hox genes, respectively [39, [41] [42] [43] . Transcription factors may need to be removed from DNA during mitosis either to allow proper chromosome condensation [44] or to allow the rearrangements of promoter structures that are important for subsequent changes in gene expression [42] .
Protein synthesis is inhibited as Xenopus embryos enter mitosis, although the mechanism by which this is accomplished is unclear [45] . We have identified two mitotic phosphoproteins that are potentially involved in translational regulation, and therefore may be important cellcycle regulators of protein synthesis. EF1␥, which is associated with the GTPase complex that regulates translational elongation, has previously been shown to be a substrate of Cdc2 [28] . Protein L18A (MP20) is a subunit of the 60S ribosomal complex whose role in translation is as yet unknown [27] . The WM6 protein (MP25) is presumed to be an RNA helicase and is highly related to translational elongation factor 4A, but a role in translation has not been established. Overproduction of the Drosophila WM6 protein in S. pombe suppresses the mitotic catastrophe induced by mutation of wee1 and overproduction of Cdc25 [46] . This phenotype is difficult to explain but could indicate that WM6 has a role in mitotic regulation.
One reason that we set out to identify mitotic phosphoproteins was to discover new regulators of mitosis. We have identified five proteins that do not share sequence similarity to previously characterized proteins. As many of the proteins that we have identified do have roles in mitosis, it seems reasonable to further characterize the newly identified proteins.
The complexity of mitotic phosphorylation
Mitosis brings many changes in cell structure. In higher eukaryotes, the nuclear envelope dissolves, the Golgi apparatus and endoplasmic recticulum fragment, actin cables and interphase microtubules disappear, chromosomes condense, and the mitotic spindle forms. Our screen has not revealed proteins that, between them, localize to all of these structures, nor identified all of the known mitotic phosphoproteins -but we do not believe that the library has been screened to saturation. Most clones were identified only once, and over 75 library pools containing mitotically phosphorylated proteins remain to be subdivided. We estimate that at least 100 additional mitotic phosphoproteins could be identified using this method: in this initial sample, approximately 1 of every 500 genes screened (0.2% of the clones) was found to encode a mitotic phosphoprotein -extrapolation to the approximately 100 000 genes in the Xenopus genome indicates that 200 genes encode mitotic phosphoproteins that could potentially be detected by our methods. It is possible that a saturating screen could identify a large percentage of the mitotic phosphoproteins, providing a global view of mitotic phosphorylation in a manner similar to the recent quantification of all RNA transcription from budding yeast [47] . Even though our screen has to date identified less than 10 percent of the predicted number of targets, the limited analysis presented in this paper suggests that a large percentage of the proteins phosphorylated during mitosis may be transcriptional and translational regulators.
The panel of MPs isolated in our screen has enabled us to begin to address general questions concerning the complexity of mitotic phosphorylation and the role of cyclin B-Cdc2 in establishing the mitotic state. Most of the clones tested (14/16) appear to be substrates of cyclin B-Cdc2 in vitro. If we assume that the panel of substrates identified is a random assortment of mitotic phosphoproteins, then this result suggests that a majority of mitotic phosphorylation reactions may be carried out by Cdc2 itself. Although phosphorylation of a substrate in vitro does not of itself reflect substrate specificity in vivo, most of the MPs contain Cdc2 consensus phosphorylation sites, and the phosphorylation in Xenopus egg extracts of all of the MPs coincides temporally with Cdc2 activation (data not shown). Although it is formally possible that the cyclin B-Cdc2 that we add to the in vitro translated substrates is activating kinases in the reticulocyte lysate, this seems unlikely considering the differentiated state of reticulocytes and the five-fold dilution of the lysate in the assay.
The possibility that additional mitotic kinases play significant roles in mitosis is suggested by the finding that purified cyclin B-Cdc2 did not phosphorylate two MPs at all (MP70 and MP105) and did not reconstitute the full mobility shifts of three others (Sox3, MP75 and MP90). At least six non-CDK kinases become activated in mitosis, as shown by chromatographically fractionating interphase and mitotic extracts, depleting CDKs from each fraction, and then assaying the fractions for the ability to phosphorylate MPs (P.T.S. and M.W.K., unpublished observations). MP phosphorylation is a simple and specific assay that should facilitate the biochemical purification and characterization of these kinase activities. Thus, our data support a model of mitotic control in which both Cdc2 and additional protein kinases become activated during mitosis to execute mitotic phosphorylation.
Screening by enzymatic activity
We have described a systematic screening technique in which proteins encoded in a cDNA library are individually tested for a chosen activity. One strength of this approach is that it can be combined with the use of Xenopus egg extracts, which can reconstitute in vitro most of the key regulatory and structural events of the cell cycle that occur in vivo. This property is important for the study of equilibrium activities such as phosphorylation.
A method for identifying mitotic phosphoproteins was described by Westendorf, Rao and Gerace [48] . They incubated filters derived from lambda gt11 libraries with mitotic extracts from HeLa cells, and then probed the filters with the MPM-2 antibody [27, 48] . Using this method, they identified 10 mitotic phosphoproteins after screening over 800 000 bacterially expressed clones [27, 48] . The Xenopus homolog, MP20, of one of them was also isolated by the method described here. The small-pool screen that we carried out had a much higher rate of detection of MPM-2-reactive proteins (about 1 in every 500 clones tested). There are three primary differences between the two screening techniques that may explain this difference in detection frequency. First, proteins translated in vitro contain post-translational modifications, and may be more properly folded than bacterially overproduced proteins on nitrocellulose filters. Second, the phosphorylation reactions in our screen were performed in solution, rather than on filters. Third, because the Xenopus cell extracts are very concentrated (40-50 mg ml -1 ), they may be a richer source of mitotic protein kinases than the HeLa cell extracts used by Westendorf et al. [48] . These differences presumably increase the efficiency with which library proteins are recognized by mitotic kinases and by the MPM-2 antibody. Moreover, it is clear that a large percentage of mitotic phosphoproteins are not recognized by MPM-2, and therefore the detection of mitotic phosphoproteins by gel-mobility shift in addition to MPM-2 antibody reactivity allows a wider range of substrates to be identified.
There are three limitations of our screening technique; first, it cannot detect kinase substrates that neither react with anti-phosphoepitope antibodies nor show a significant gel-mobility shift upon phosphorylation. Second, proteins that would be inaccessible to cytoplasmic mitotic kinases when localized normally may be aberrantly phosphorylated in the extracts; examples of such proteins may be MP105, which is related to a GPIanchored protein, and MP42, which contains a potential signal sequence. Third, in pools of approximately 100 clones, an average of 24 35 S-labeled protein bands were detected, suggesting that not all of the cDNAs were being assayed. This problem, however, can be largely circumvented by using smaller pools of clones (approximately 36 clones per pool; see Materials and methods for details).
Other applications of the small-pool protein screen
The protein pool screening approach can be adapted to a wide range of existing in vitro and in vivo assays. Using small pools of library proteins, screens for substrates, interactions, or activities can be carried out [49] . Screens like the one we report here should be broadly applicable for the identification of substrates of any purified or partially purified enzymatic activity. Indeed, this approach has already been adapted successfully for screening for proteins that are specifically degraded during mitosis (T.J.M. and M.W.K., unpublished observations) as well as for proteins that are specifically degraded by ICE proteases (V. Cryns and J. Yuan, and D. Xue and R. Horvitz, personal communications). We have also modified this approach in order to identify substrates of a single kinase, cyclin E-Cdk2; this was accomplished by comparing the gel mobility of labeled protein pools after incubation in interphase extracts in either the presence or absence of the specific kinase inhibitor p21 (P.T.S. and M.W.K., unpublished observations).
Conclusions
In this study, we have described a systematic and broadly applicable approach for identifying mitotic phosphoproteins. Further characterization of the 20 kinase substrates that we have thus far isolated should provide new insights into their roles in both mitosis and the signal-transduction cascades that orchestrate cell-cycle states. The general approach we have developed is not limited to identifying kinase substrates, but can be used, at least in principle, to systematically identify substrates of enzymatic activities that have previously proven intractable to genetic or biochemical isolation.
Materials and methods
Materials
All chemicals were supplied by Sigma unless stated otherwise. MPM-2 antibody ascites fluid was prepared as described previously [9] . INCENP antibodies were a generous gift from W. Earnshaw [34] and Cdc2 antibodies have been described previously [50] . Immunoblots were performed as described [51] . Fusion proteins consisting of glutathione S-transferase fused to Xenopus cyclins (GST-cyclins) were expressed in E. coli, purified by glutathione affinity chromatography as described [13] and stored in XB (10 mM HEPES pH 7.7, 1 mM MgCl 2 , 0.1 mM CaCl 2 , 100 mM KCl, 50 mM sucrose, 1 mM DTT and 10 g ml -1 leupeptin, pepstatin A and chymostatin) at -80°C until use. Initial sequencing to identify clones was performed on one strand according to the manufacturer's directions (US Biochemical Corporation); complete sequencing of clones was performed on both strands in polymerase chain reactions in the presence of 4 fluorescent dideoxy terminators (Perkin Elmer), and analyzed on an Applied Biosystems 373A DNA sequencer by the Harvard Medical School biopolymers facility.
Preparation of cDNA and protein pools, and progressive subdivision of positive pools to single clones
Previously, we have used pools of library cDNA plasmids (containing 100 clones per pool) to construct RNA pools which were then translated and assayed in vivo, in Xenopus oocytes [20, 21] or Xenopus embryos [52] . In this study, we have used the same pools of cDNAs to directly construct pools of proteins in vitro. Protein pools were prepared using the TnT Coupled Reticulocyte Lysate System from Promega, according to the manufacturer's instructions, except that the reaction volume was scaled down to 5 or 10 l and we added 0.1-0.5 g of pooled plasmid cDNA per reaction. Radioactivelylabeled protein pools were prepared by carrying out a 10 l translation reaction in the presence of 8 Ci [ 35 S]methionine (1000 Ci mmol -1 ) and omitting unlabeled methionine from the amino-acid mix. Protein pools were stored on ice and used on the day of synthesis. Positive pools were subdivided as described [49] .
In pools of approximately 100 clones, an average of 24 35 S-labeled protein bands were detected. The low number of translation products suggests that only one quarter of the cDNAs within the library were being tested. We tested smaller pools of cDNAs to determine if we could detect a greater percentage of the clones. When tested individually, only 63% of the plasmids from the library could give a translatable product, which only partially explains the low number of proteins translated in pools of 100 clones (P.T.S. and M.W.K., unpublished observations). When smaller pools of 32 and 24 clones/pool were transcribed and translated they produced an average of 22 and 18 bands (P.T.S. and M.W.K., unpublished observations). As 63% of clones in this library can give a protein product, then these smaller pools should yield an average of 20 and 18 bands, respectively; therefore, most of the cDNAs were giving recognizable product when smaller pools were used.
Preparation of interphase and mitotic Xenopus extracts
Interphase extracts (IE) were prepared from unfertilized eggs obtained from Xenopus as described previously [23] , with the following modifications. De-jellied meiotically arrested eggs in 1× MMR (5 mM HEPES pH 7.4, 100 mM NaCl, 2 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 ) were activated by the addition of 2 g ml -1 A23187, a calcium ionophore, kept at 18°C and then crushed 50 min later. Just before freezing in liquid N 2 , 100 g ml -1 cycloheximide and 10% glycerol were added; extracts were stored at -80°C until used. Cycloheximidepresoaked IE were prepared as above except that the eggs were soaked for 15 min in 100 g ml -1 cycloheximide (which was contained in all subsequent buffers) before ionophore activation and that the extracts were prepared approximately 20 min after activation. Mitotic extracts were prepared by driving IE into mitosis by the addition of 66 nM nondegradable GST-cyclin B for 30 min at room temperature (IE + cyclin B). 
Identification of MPs by retarded gel mobility
MPM-2 immunoprecipitation of in vitro translated proteins
[ 35 S]methionine-labeled protein pools (4 l) were mixed with 4 l of either IE or IE + cyclin B containing 0.5 M okadaic acid (CalBiochem), and the reaction mixture was then incubated at room temperature for 30 min. MPM-2 beads (15 l; prepared as in [53] ) were washed 2 times with 500 l EB (80 mM ␤-glycerolphosphate, 20 mM EGTA, 10 mM MgCl 2 ) containing 5 mM NaF, and an additional 10 l EB containing 5 mM NaF was added to the beads. Extracts (3 l) and labeled pooled protein mixture were added to the MPM-2 bead slurry and subsequently rotated for 1 h at 4°C. The beads were washed 3 times in 500 l of MPM-2 wash buffer (EB containing 5 mM NaF, 500 mM NaCl, 1.0% NP40), then 20 l of 2× sample buffer was added and the samples were boiled for 5 min. Translation mixture (1 l) from each pool was directly diluted into sample buffer and loaded onto 5-15% SDS-polyacrylamide gradient gels adjacent to the proteins immunoprecipitated from IE and IE + cyclin B extracts [54] .
In the MPM-2 immunoprecipitation primary screen, the phosphatase inhibitor okadaic acid, which stabilizes the mitotic state, was added to the mitotic extracts to increase the sensitivity of the assay. Okadaic acid increased the percentage of the clone MP90 precipitated by MPM-2 over 5-fold, but for most of the positive clones had little or no effect on the amount of protein precipitated by MPM-2 (data not shown). Two clones (Vox1 and BRG1) exhibited a phosphatase-sensitive reduction in SDS-PAGE mobility after incubation in mitotic extracts but were only immunoprecipitated by MPM-2 in the presence of okadaic acid (data not shown). Okadaic acid was not added when single proteins were assayed
Fertilization of Xenopus eggs, and early embryonic time course
Xenopus eggs were obtained as described [23] by gentle squeezing into 1× MMR. The eggs were fertilized with fresh sperm, activated by the addition of nine volumes of water, and de-jellied about 10 min later with 2% cysteine in 1× XB salts (1 mM CaCl 2 , 1 mM MgCl 2 , 100 mM KCl). At each indicated time point, five eggs were added to 100 l stabilization buffer (40 mM ␤-glycerophosphate, 20 mM NaF, 10 mM EDTA, stored at 0°C), homogenized by pipetting up and down, and then spun for 15 sec at 14 000 r.p.m. in a Sorval MC15 microfuge to remove lipid and yolk platelets. Immediately after centrifugation, 10 l of the supernatant was frozen in liquid N 2 for histone H1 kinase assays. These were carried out as described [23] , except that the final MgCl 2 concentration was 11 mM. The rest of the sample was diluted into sample buffer and stored at -20°C until the samples were loaded onto a 7% gel for immunoblot analysis. For graphic analysis, the results of the immunoblot and histone H1 kinase assays were digitized, and the amount of phosphorylated INCENP and histone H1 kinase activities were quantitated using the IP lab gel version 1.5 (Signal Analycs).
Because there was some variability in the amount of total INCENP signal on the blot, the amount of phosphorylated INCENP was divided by the total INCENP signal, and this ratio was plotted as a percentage of maximal ratio differences. Histone H1 kinase activity was plotted as the percentage of maximal total activity in the sample.
Kinase assays with purified cyclin B1-Cdc2 complexes
GST-cyclin B1-Cdc2 was purified by rocking 100 l IE + cyclin B extract, diluted into 300 l IP buffer (100 mM NaCl, 50 mM ␤-glycerophosphate pH 7.2, 5 mM EDTA, 0.1% Triton X-100, 1 mM DTT, and 10 g ml -1 leupeptin, pepstatin A and chymostatin), with 100 l glutathione-agarose beads for 1 h at 4°C. The beads were washed four times with IP buffer, two times in kinase buffer (50 mM NaCl, 20 mM HEPES pH 7.2, 10 mM MgCl 2 , 2 mM EDTA, 0.02% Triton X-100), and then eluted with 100 l of XB containing 5 mM reduced glutathione. Control solutions were similarly prepared except that agarose beads without the affinity ligand were used (Biorad Affigel 102). For in vitro kinase assays 5 l of either IE, IE + cyclin B, purified GST-cyclin B1-Cdc2, or Cdc2 control solution was incubated with 1 l of the indicated protein for 10 min at room temperature, and the reaction was quenched with sample buffer. Half of the IE + cyclin B reaction (which was scaled up 2-fold) was removed before addition of sample buffer, and incubated with 5 g calf intestinal phosphatase (Boehringher Mannheim) for 30 min at 37°C.
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